PE20011319A1 - Un estuche de combinacion usado en el tratamiento del paludismo - Google Patents
Un estuche de combinacion usado en el tratamiento del paludismoInfo
- Publication number
- PE20011319A1 PE20011319A1 PE2001000469A PE2001000469A PE20011319A1 PE 20011319 A1 PE20011319 A1 PE 20011319A1 PE 2001000469 A PE2001000469 A PE 2001000469A PE 2001000469 A PE2001000469 A PE 2001000469A PE 20011319 A1 PE20011319 A1 PE 20011319A1
- Authority
- PE
- Peru
- Prior art keywords
- treatment
- malaria
- kit used
- combination kit
- combination
- Prior art date
Links
- 201000004792 malaria Diseases 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- AEUAEICGCMSYCQ-UHFFFAOYSA-N 4-n-(7-chloroquinolin-1-ium-4-yl)-1-n,1-n-diethylpentane-1,4-diamine;dihydrogen phosphate Chemical compound OP(O)(O)=O.ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 AEUAEICGCMSYCQ-UHFFFAOYSA-N 0.000 abstract 1
- 241000223810 Plasmodium vivax Species 0.000 abstract 1
- 229960002328 chloroquine phosphate Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN501MU2000 | 2000-05-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20011319A1 true PE20011319A1 (es) | 2002-03-02 |
Family
ID=11097250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000469A PE20011319A1 (es) | 2000-05-31 | 2001-05-23 | Un estuche de combinacion usado en el tratamiento del paludismo |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7404962B1 (enExample) |
| EP (1) | EP1292306B1 (enExample) |
| JP (1) | JP2004505017A (enExample) |
| KR (1) | KR20030025926A (enExample) |
| AP (1) | AP1435A (enExample) |
| AR (1) | AR028458A1 (enExample) |
| AT (1) | ATE314848T1 (enExample) |
| AU (2) | AU2879001A (enExample) |
| BR (1) | BR0005247A (enExample) |
| CA (1) | CA2413775C (enExample) |
| CR (1) | CR6835A (enExample) |
| CZ (1) | CZ296875B6 (enExample) |
| DE (2) | DE60025403T2 (enExample) |
| DK (1) | DK1292306T3 (enExample) |
| EC (1) | ECSP003694A (enExample) |
| ES (1) | ES2200729T3 (enExample) |
| GT (1) | GT200000187A (enExample) |
| HK (1) | HK1052467B (enExample) |
| HN (1) | HN2001000118A (enExample) |
| HU (1) | HUP0301925A3 (enExample) |
| MX (1) | MXPA02011883A (enExample) |
| NO (1) | NO324774B1 (enExample) |
| OA (1) | OA12276A (enExample) |
| PE (1) | PE20011319A1 (enExample) |
| PL (1) | PL200748B1 (enExample) |
| SV (1) | SV2002000201A (enExample) |
| WO (1) | WO2001091535A2 (enExample) |
| ZA (1) | ZA200209726B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007098047A2 (en) * | 2006-02-16 | 2007-08-30 | The Mclean Hospital Corporation | Methods and compositions for the treatment of parkinson's disease |
| US8658648B2 (en) | 2008-12-05 | 2014-02-25 | Designmedix, Inc. | Modified chloroquines with single ring moiety or fused ring moiety |
| WO2010144102A1 (en) * | 2009-06-09 | 2010-12-16 | The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Material Command | Pentafluorosulfanyl analogs of mefloquine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431807A (en) * | 1980-06-12 | 1984-02-14 | The United States Of America As Represented By The Secretary Of The Army | 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines |
| US5219865A (en) * | 1987-05-08 | 1993-06-15 | Hoechst Aktiengesellschaft | Pharmaceutical combination for the prophylaxis and therapy of malaria |
| US5373005A (en) * | 1988-04-20 | 1994-12-13 | Merrell Dow Pharmaceuticals Inc. | Despiramine in the treatment of drug-resistant malarial infections |
| US5270037A (en) * | 1990-07-12 | 1993-12-14 | Boehringer Ingelheim Gmbh | Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections |
| NZ246606A (en) * | 1992-02-07 | 1995-09-26 | Ciba Geigy Ag | Antimalarial compostions containing a synergistic combination of benflumetol and quinine or a derivative thereof |
-
2000
- 2000-08-30 PL PL372718A patent/PL200748B1/pl not_active IP Right Cessation
- 2000-08-30 ES ES00993875T patent/ES2200729T3/es not_active Expired - Lifetime
- 2000-08-30 OA OA1200200359A patent/OA12276A/en unknown
- 2000-08-30 AP APAP/P/2002/002672A patent/AP1435A/en active
- 2000-08-30 AU AU2879001A patent/AU2879001A/xx active Pending
- 2000-08-30 WO PCT/IN2000/000081 patent/WO2001091535A2/en not_active Ceased
- 2000-08-30 US US10/296,215 patent/US7404962B1/en not_active Expired - Fee Related
- 2000-08-30 AT AT00993875T patent/ATE314848T1/de active
- 2000-08-30 AU AU2001228790A patent/AU2001228790B2/en not_active Ceased
- 2000-08-30 HK HK03104811.6A patent/HK1052467B/en not_active IP Right Cessation
- 2000-08-30 EP EP00993875A patent/EP1292306B1/en not_active Expired - Lifetime
- 2000-08-30 HU HU0301925A patent/HUP0301925A3/hu unknown
- 2000-08-30 DE DE60025403T patent/DE60025403T2/de not_active Expired - Lifetime
- 2000-08-30 JP JP2001587559A patent/JP2004505017A/ja active Pending
- 2000-08-30 MX MXPA02011883A patent/MXPA02011883A/es active IP Right Grant
- 2000-08-30 KR KR1020027016169A patent/KR20030025926A/ko not_active Ceased
- 2000-08-30 CZ CZ20024071A patent/CZ296875B6/cs not_active IP Right Cessation
- 2000-08-30 DK DK00993875T patent/DK1292306T3/da active
- 2000-08-30 DE DE0001292306T patent/DE00993875T1/de active Pending
- 2000-08-30 CA CA002413775A patent/CA2413775C/en not_active Expired - Fee Related
- 2000-10-05 EC EC2000003694A patent/ECSP003694A/es unknown
- 2000-10-13 SV SV2000000201A patent/SV2002000201A/es unknown
- 2000-10-25 GT GT200000187A patent/GT200000187A/es unknown
- 2000-11-06 BR BR0005247-7A patent/BR0005247A/pt not_active Application Discontinuation
-
2001
- 2001-05-14 AR ARP010102288A patent/AR028458A1/es unknown
- 2001-05-23 PE PE2001000469A patent/PE20011319A1/es not_active Application Discontinuation
- 2001-05-30 HN HN2001000118A patent/HN2001000118A/es unknown
-
2002
- 2002-11-28 CR CR6835A patent/CR6835A/es not_active Application Discontinuation
- 2002-11-29 ZA ZA200209726A patent/ZA200209726B/en unknown
- 2002-11-29 NO NO20025765A patent/NO324774B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0509505A (pt) | método e kit útil para branqueamento de uma superfìcie dental | |
| AR073345A1 (es) | Composiciones y metodos para el blanqueamiento dental | |
| HN2000000266A (es) | Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto. | |
| BR0211390A (pt) | Tratamento de infecções da unha com no | |
| NO20034012L (no) | Innretning og fremgangsmåte ved dyrehold | |
| MA28334A1 (fr) | Compositions pharmaceutiques antivirales | |
| PA8513601A1 (es) | Composiciones farmaceuticas de inhibidores de la glucogenofosforilasa | |
| FR2869231A1 (fr) | Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine | |
| AR060739A1 (es) | Composiciones orales que comprenden polimeros de siloxano | |
| AR080216A2 (es) | Composiciones farmaceuticas que contienen una proteina de fusion de vih | |
| HN2008000278A (es) | Asociacion de un agente hipnotico de duracion de accion larga y un agente hipnotico de duracion de accion corta y su aplicacion terapeutica | |
| CY1112281T1 (el) | Αναστολεις διπεπτιδυλ πεπτιδασης για τη θεραπεια του διαβητη | |
| AR045203A1 (es) | Formas de dosificacion de inhibidores de la proteina de transferencia de colesteril ester e inhibidores de la hmg-coa reductosa | |
| ES2144989T1 (es) | Utilizacion de un copolimero de acido metacrilico de tipo c como agente, o co-agente, de disgregacion. | |
| ZA200700532B (en) | Structured body wash | |
| MA31305B1 (fr) | Administration hebdomadaire d'inhibiteurs de la dipeptidyle peptidase | |
| ECSP045153A (es) | Metodo y composición para aumentar la potencia de un analgésico de narcotico. | |
| PE20060594A1 (es) | Composicion farmaceutica que contiene un agonista de ppar | |
| DE60230500D1 (de) | Hochkinetische energie zur bearbeitung von material einsetzendes verfahren | |
| AR034200A1 (es) | Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza | |
| AR047279A1 (es) | Composicion detergente liquida | |
| CL2024003328A1 (es) | Métodos para el tratamiento de linfoma. | |
| PE20011319A1 (es) | Un estuche de combinacion usado en el tratamiento del paludismo | |
| AR029092A1 (es) | Composiciones para el tratamiento del cabello | |
| MXPA05002399A (es) | Fibras celulosicas reticuladas con acido poliacrilico blanqueadas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |